Atlas Trials

INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders

Clinical trial NCT01788072 · COMPLETED

Trial details

NCT number
NCT01788072
Sponsor
Holland Bloorview Kids Rehabilitation Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2014-06-01
Primary completion
2017-08-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.